Global Neuroleptics Market Size Hit USD 26.75 Billion at a CAGR of 7.0 in 2030

Published March 28, 2023

The global neuroleptics market size was USD 14.43 Billion in 2021 and is expected to register a revenue CAGR of 7.0% over the forecast period, according to the latest report by Reports and Data.

One of the main factors influencing the market’s revenue growth is the rising prevalence of mental health issues including schizophrenia and bipolar disorder. Anxiety disorders are thought to affect close to half of all individuals with a diagnosis of depression. To promote mental health and avert mental health issues, the World Health Organization (WHO) has urged member nations to develop “mental health action plans.” Although depression affects people of all ages, from all backgrounds, and across all cultures, some communities are disproportionately affected. Also, the prevalence of psychotic diseases is rising internationally, which is boosting market revenue growth.

Companies profiled in the market report include AbbVie Inc., Alkermes, Bristol-Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Lilly, Johnson & Johnson Services, Inc., Otsuka Holdings Co., Ltd., AstraZeneca, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Get a sample of the report @

Market Overview:

The research report assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. The report estimates the market size, market growth, and provides an accurate forecast for the key segments of the market for the forecast period of 2022-2030. The report also covers an in-depth analysis of the key competitors of the market, along with their growth strategies and business expansion plans.

The Neuroleptics Market has been segmented into key regions of the world and offers an analysis of growth rate, market share, market size, current and emerging trends, production and consumption ratio, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players in each region. A country-wise analysis of the market is offered in the report to gain a better understanding of the regional spread and progress of the Neuroleptics Market.

Further key findings from the report suggest,

  • The first generation and second generation of neuroleptics have separate markets in the global market based on therapeutic class. With the wide distribution of second-generation medications, the second-generation segment had the biggest revenue share in 2021. Only a few of the well-known second-generation antipsychotic medications currently on the market include SEROQUEL XR, clozapine (Clozaril), ZYPREXA, VRAYLAR, INVEGA HAFYERA, and Rexulti. Furthermore, it is anticipated that the development of the market would be fueled by the enhanced safety and enhanced efficacy of these more recent generations of pharmaceuticals. An antipsychotic of the second generation called lurasidone has recently received FDA approval for the treatment of schizophrenia. Lurasidone, like the vast majority of other second-generation antipsychotics, is totally antagonistic to both dopamine D2 and serotonin 5HT2A receptors.
  • The North American market will account for the greatest revenue share in 2021, according to regional analysis. This is due to the population’s rising prevalence of mental diseases like schizophrenia. Because of their developed healthcare infrastructure, enhanced regulatory environment, increased frequency of mental illnesses, and government support, countries in this region have superior mental healthcare systems. Also, businesses employ a variety of commercial strategies to preserve their place in the neuroleptics industry, including partnerships, product launches, acquisitions, and mergers.
  • For instance, Neurocrine Biosciences and Sosei Group Corporation established a partnership to develop a novel brand of protein inhibitor on November 29, 2021. Neurocrine Biosciences will investigate this relationship to improve medicines for a variety of neuropsychiatric disorders.

To understand how our Neuroleptics Market can bring difference to your business strategy:

For the purpose of this report, Reports and Data has segmented the global neuroleptics industry into Therapeutic Class Outlook, Application Outlook, End-use Outlook, Regional Outlook:

Therapeutic Class Outlook (Revenue, USD Billion; 2019-2030)

  • First Generation
  • Second Generation

Application Outlook (Revenue, USD Billion; 2019-2030)

  • Schizophrenia
  • Dementia
  • Bipolar Disorder
  • Depression
  • Others

End-use Outlook (Revenue, USD Billion; 2019-2030)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook (Revenue, USD Billion; 2019-2030)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Request a customization of the report :

 Key Advantages of Neuroleptics Market Report:

  • Identification and analysis of the market size and competition
  • Qualitative and quantitative analysis of the market data
  • Data validated by industry experts after extensive primary and secondary research
  • Extensive regional analysis of the Neuroleptics industry
  • Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
  • SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
  • Feasibility analysis and investment analysis to enable strategic investment decisions
  • Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively, all aspects of the Neuroleptics Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web:
Check our upcoming research reports @
Visit our blog for more industry updates @

Image Credit

Browse More Reports:


The post Global Neuroleptics Market Size Hit USD 26.75 Billion at a CAGR of 7.0 in 2030 appeared first on Market O Graphics.

Reports and Data